Earnshaw SR, McDade CL, Zanotti G, Farkouh R, Strutton D. Cost-effectiveness of 2+1 dosing of 13-valent pneumococcal conjugate vaccine compared with 2+1 dosing of 10-valent conjugate vaccine in preventing pneumococcal disease in Canada. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A275.
Spinner DS, Mladsi D, Walter J, Ziemiecki R, Stafford-Smith M, Taekman J, Faulkner E. Clinical trial learning curves may impact both clinical and economic outcomes and influence health technology assessment and reimbursement decision making. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A356.
Brogan AJ, Talbird SE, Cohen C. Cost-effectiveness of nucleoside reverse transcriptase inhibitor pairs in efavirenz-based regimens for treatment-naïve adults with HIV infection in the United States. Value Health. 2011 Jul 1;14(5):657-554.